A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...
A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which ...
A large new study of more than 40,000 patients from heart researchers at Intermountain Health in Salt Lake City finds that a zero coronary artery calcium score continues to be an accurate indicator of ...
Researchers have demonstrated a novel approach to generating terahertz (THz) radiation using N-polar AlGaN/GaN high-electron-mobility transistors (HEMTs) under asymmetric boundary conditions. This ...
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, researchers report ‘seeding’ this accumulation through fragments of the culprit ...
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug ...
A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate ...
In this unblinded randomized clinical trial, prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring coagulation factor ...
A large new study of more than 40,000 patients from heart researchers at Intermountain Health in Salt Lake City finds that a zero coronary artery calcium score continues to be an accurate indicator of ...
The ESC Clinical Consensus Statement offers updated guidance to healthcare professionals on selecting patients for conduction system pacing. Patient perspective has been incorporated to ensure a ...
The efficacy of finerenone was consistent regardless of atrial fibrillation status in this study. New-onset atrial fibrillation was associated with a substantially higher risk of subsequent outcomes.
In his 30th year at Pacific Northwest National Laboratory, Zheming Wang is elected a AAAS Fellow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback